• Accessibility Information
  • EN
  • ID
IA-CEPA ECP Katalis IA-CEPA ECP Katalis
  • About
    • About Katalis
    • About IA-CEPA
  • Activities
    • Current
    • Completed
  • Business Opportunities
  • Newsroom
    • Blog
    • Press Release
    • Events
    • The Katalis Podcast
    • Publications
    • Greetings from the Ministers
  • Vacancies
    • Individual Vacancies
    • Consulting Opportunities
  • Submit Your Idea
press release
  • Press Release
  • April 6, 2022

Katalis backs Indonesian-Australian consortium to explore potential development of new hospitals in West Java

JAKARTA, 6 April 2022 – Two regencies in West Java have been selected as the location for bankable feasibility studies for the development of new hospitals. Supported by the Indonesia-Australia Comprehensive Economic Partnership Agreement (IA-CEPA) Economic Cooperation Program Katalis, the activity valued at AUD 594,000 (approximately IDR 6.3 billion) seeks to catalyse health and economic recovery for West Java residents, address infrastructure needs, and at the same time provide mutual benefits for Indonesian and Australian businesses.

The selection of Karawang Regency and another one to be confirmed in the next few weeks was based on needs identified by the Provincial Government of West Java and a consortium consisting of Sanusa Medika Group (SMG), a joint venture between Aspen Medical and Docta Pty Ltd from Australia, and PT Jasa Sarana, an Indonesian state-owned enterprise. The joint venture is collectively known as Sanusa Medika Hospitals (SMH). In both locations, the project seeks to increase hospital bed capacity and health facilities to meet the growing needs of the population. If successful, Sanusa Medika intends to expand and establish an additional 21 hospital facilities across West Java.

“This is a major first step towards realising the partnership potential at the regional level within the Indonesia-Australia Comprehensive Economic Partnership Agreement. The feasibility studies will potentially pave the way for investment in the first two new hospitals, with the possibility of others following in the short and medium term, and overall will contribute to the West Java Health Infrastructure Program. I’m very happy that the ground-breaking of the first of these hospitals will be held in June this year,” said Ridwan Kamil, West Java Governor.

“I am delighted the IA-CEPA Katalis program is supporting feasibility studies for an Australian-Indonesian consortium to develop new hospitals in West Java. This is yet another example of the health and commercial partnerships between Australia and Indonesia, which are going from strength to strength. Through IA-CEPA we look forward to continuing and deepening commercial ties between our two countries in the coming years,” said HE Penny Williams, Australian Ambassador to Indonesia.

The studies are designed to draw a full spectrum of human, industry, commercial, financial, organisational, management and institutional capabilities in both Indonesia and Australia to plan, design, structure, finance, construct, commission and operate hospitals and clinics in West Java. Early analysis suggests each hospital could employ more than 300 health workers and more than 200 non-health workers annually. Given the high demand for services for women, children and reproductive healthcare in the province, the activity will also provide an opportunity for broader healthcare outcomes for women and children.

“The banking feasibility studies for the two new hospitals in West Java have met all our investment criteria. There is a clear commercial benefit from the investment for Australian and Indonesian companies involved in this highly scalable activity. Not only will it create jobs in the health sector, many of which will be for women, this activity also leverages investment for related activities,” said Paul Bartlett, Director of IA-CEPA ECP Katalis.

“Aside from causing a shock to the healthcare system, the pandemic has also led to rising consumer expectations for better healthcare experiences. Through our presence in West Java, we seek to develop a health ecosystem and at the same time deliver world-class standards and innovation to those in need of essential services,” said Dr. Andrew Rochford, President Director and CEO of Sanusa Medika Group.

Related Posts:

  • PR Sky Credit
    Australian fintech SkyCredit Group eyes Indonesian electric two-wheelers market January 30, 2023
  • PrivyID
    Indonesian digital identity and security services provider PrivyID taps into the Australian market, partners with Katalis to derisk expansion strategy January 17, 2023
  • Grains Australia
    Online learning program in grain technology and mill processing aims to upskill Indonesian flour mills November 15, 2022
  • TEI Business Forum
    The “37th Trade Expo Indonesia” encourages Indonesian exporters to explore the Australian market October 22, 2022
IA-CEPA ECP Katalis

Our goal is to maximise IA-CEPA benefits for Indonesia and Australia: improved market access, increased two-way trade and investment, and inclusive economic growth in Indonesia.

Useful Links

  • Contact Us
  • FAQ
  • GEDSI Toolkit
  • Privacy Policy
  • Cookie Policy
  • Accessibility Statement
  • Sitemap

Subscribe to our newsletter

Loading
© Copyright IA-CEPA ECP Katalis
The website uses cookies to ensure you get the best experience on our website. Read more
Accept all
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT